Heart Failure Clinical Trial

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

Summary

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.

View Full Description

Full Description

The study consists of two consecutive parts: Part A and Part B. Part A will evaluate the safety and efficacy of two doses of AT-001 vs placebo. The primary objective of Part A is to demonstrate that AT-001 improves or prevents the decline of functional capacity in patients with Diabetic Cardiomyopathy. Part B is an extension of at least 12 months that will evaluate the safety and efficacy of chronic administration of AT-001 vs placebo in the same patients who had previously been evaluated in Part A. Assessments in Part B will include safety endpoints and exploratory clinical efficacy endpoints, i.e. death and hospitalization due to a cardiac event.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Type 2 Diabetes Mellitus
Diabetic cardiomyopathy
Peak VO2 < 75% of predicted normal value based on age and gender

Exclusion Criteria:

Prior diagnosis or signs/symptoms of overt/symptomatic heart failure / stage C heart failure
Prior echocardiogrphic measurement of ejection fraction (EF) < 40%
Prior acute coronary syndrome (ACS), coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), coronary artery disease (CAD) or stroke
Severe or moderate cardiac valve disease requiring intervention
Clinically significant arrhythmia
Prior diagnosis of congenital, infective, toxic, infiltrative, post-partum, or hypertrophic cardiomyopathy
Blood pressure > 140 mmHg (systolic) or > 90 mmHg (diastolic) at screening
HbA1c >8.5% at screening
Severe disease that would impact the performance of a cardio-pulmonary exercise test

Study is for people with:

Heart Failure

Phase:

Phase 3

Estimated Enrollment:

675

Study ID:

NCT04083339

Recruitment Status:

Active, not recruiting

Sponsor:

Applied Therapeutics, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 75 Locations for this study

See Locations Near You

Westside Medical Associates of Los Angeles
Beverly Hills California, 90211, United States
University of California, San Diego (UCSD)
La Jolla California, 92093, United States
Clinical Trials Research
Lincoln California, 95648, United States
University of California - Irvine Medical Center
Orange California, 92868, United States
Metabolic Institute of America
Tarzana California, 91356, United States
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Torrance California, 90509, United States
ALL Medical Research, LLC
Cooper City Florida, 33024, United States
New Generation of Medical Research
Hialeah Florida, 33016, United States
Broward Research Center
Pembroke Pines Florida, 33024, United States
Progressive Medical Research
Port Orange Florida, 32127, United States
UnityPoint Health - Methodist Hospital
Peoria Illinois, 61602, United States
Brigham and Women's Hospital
Boston Massachusetts, 02115, United States
Universty of Mississippi Medical Center
Jackson Mississippi, 39216, United States
St. Louis Heart and Vascular Cardiology
Saint Louis Missouri, 63136, United States
Chear Center LLC
Bronx New York, 10455, United States
Montefiore Medical Center
Bronx New York, 10467, United States
Cleveland Clinic
Cleveland Ohio, 44195, United States
Remington Davis, Inc.
Columbus Ohio, 43215, United States
South Oklahoma Heart Research
Oklahoma City Oklahoma, 73135, United States
Mountain View Clinical Research - Greer
Greer South Carolina, 29651, United States
Mountain View Clinical Research
Greer South Carolina, 29651, United States
Holston Medical Group
Kingsport Tennessee, 37660, United States
Dallas Diabetes Research Center
Dallas Texas, 75230, United States
Southwest Family Medicine Associates
Dallas Texas, 75235, United States
University of Texas Southwestern
Dallas Texas, 75390, United States
Juno Research, LLC - Northwest Site
Houston Texas, 77040, United States
Juno Research, LLC - Southwest Houston Site
Houston Texas, 77074, United States
FMC Science
Lampasas Texas, 76550, United States
Prince Charles Hospital
Chermside Queensland, 4032, Australia
CORE Research Group Pty. Ltd.
Milton Queensland, 4064, Australia
AusTrials
Taringa Queensland, 4068, Australia
University of Tasmania at Hobart
Hobart Tasmania, 7001, Australia
Barwon Health-University Hospital Geelong
Geelong Victoria, 3220, Australia
Austin Health
Heidelberg Victoria, 3084, Australia
Baker Heart and Diabetes Institute
Melbourne Victoria, 3004, Australia
C-Endo - Endocrinology Centre
Calgary Alberta, T2V 4, Canada
BC Diabetes
Vancouver British Columbia, V5Y 3, Canada
LMC Diabetes & Endocrinology Ltd. - Brampton
Brampton Ontario, L6S 0, Canada
LMC Diabetes & Endocrinology Ltd. - Thornhill
Concord Ontario, L4K 4, Canada
LMC Diabetes & Endocrinology Ltd. - Etobicoke
Etobicoke Ontario, M9R 4, Canada
Centre for Studies in Family Medicine, Western Centre for Public Health and Family Medicine, Western University
London Ontario, N6G 2, Canada
LMC Diabetes & Endocrinology Ltd. - Toronto
Toronto Ontario, M4G 3, Canada
Ecogene-21
Chicoutimi Quebec, G7H 7, Canada
Institut Universitaire de Cardiologie et de Pneumologie De Quebec
Québec Quebec, G1V 4, Canada
Edumed s.r.o.
Jaroměř , 55101, Czechia
Nemocnice Pardubickeho kraje, a.s., Nemocnice Pardubice
Pardubice , 532 0, Czechia
Vseobecna fakultni nemocnice v Praze
Praha , 128 0, Czechia
Hôpital Jean-Verdier - AP-HP; Service Endocrinologie Diabétologie Nutrition
Bondy , 93140, France
CHU Henri Mondor
Créteil , 94000, France
CHU de Nantes, Clinique d'Endocrinologie
Nantes , 44093, France
Centre Hospitalier de Valenciennes
Valenciennes , 59322, France
Klinikum Frankfurt (Oder) GmbH
Frankfurt (Oder) Brandenburg, 15236, Germany
Herz-und Diabeteszentrum NRW Universitaetsklinik der Ruhr-Universitaet Bochum
Bad Oeynhausen North Rhine Westphalia, 32545, Germany
Cardiologicum Pirna und Dresden
Dresden Saxony, 01277, Germany
Klinische Forschung Berlin GbR
Berlin , 10787, Germany
ZKS - Zentrum Klinische Studien Sudbrandenburg GmbH
Elsterwerda , 04910, Germany
Erik Yee Mun George Fung
Sha Tin , , Hong Kong
Prince of Wales Hospital; Chinese University of Hong Kong; Dept of Medicine and Therapeutics
Sha Tin , , Hong Kong
Centrum Chorob Serca w USK
Wrocław Borowska, 50-55, Poland
NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny
Białystok , 15-43, Poland
Topolowa MEDICENTER Mrózek & wspólnicy sp.j.
Kraków , 31-50, Poland
Centrum Twojego Zdrowia
Kraków , 31-52, Poland
Praktyka Lekarska Ewa Krzyzagorska
Poznań , 61-65, Poland
Prywatny Gabinet Lekarski Centrum Medyczne Diabetika
Radom , 26-60, Poland
Centrum Medyczne Medyk Stanislaw Mazur Sp. z o.o. SK
Rzeszów , 35-00, Poland
4 Wojskowy Szpital Kliniczny z Poliklinika Samodzielny Publiczny ZOZ we Wroclawiu
Wrocław , 50-98, Poland
ETG Lodz
Łódź , 90-30, Poland
Hospital Germans Trias i Pujol
Badalona Barcelona, 08916, Spain
Hospital Clinico Universitario Virgen de la Arrixaca
El Palmar Murcia, 30120, Spain
Hospital Abente y Lago (Complejo Universitario de la Coruña)
A Coruña , 15001, Spain
Hospital de la Santa Creu i Sant Pau Barcelona
Barcelona , 08041, Spain
Hospital Universitario Reina Sofia
Córdoba , 14004, Spain
Hospital Universitario Virgen Macarena
Sevilla , 41009, Spain
Hospital Clinico Universitario de Valencia
Valencia , 46010, Spain
Ninewells Hospital & Medical School
Dundee , DD1 9, United Kingdom
CPS Research
Glasgow , G20 0, United Kingdom
Glenfield hospital
Leicester , LE3 9, United Kingdom
Barts and The London School of Medicine & Dentistry
London , EC1M , United Kingdom
Wythenshawe Hospital
Manchester , M23 9, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 3

Estimated Enrollment:

675

Study ID:

NCT04083339

Recruitment Status:

Active, not recruiting

Sponsor:


Applied Therapeutics, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider